A Banned Chemical That Is Still Causing CancerApril 3, 2024DLBCLPatient & Survivor CareMixed TopicsBusiness of MedicineAggressive LymphomasALLAML
FDA OKs Danicopan Add-On for Extravascular Hemolysis in Adults With PNHApril 2, 2024Bleeding DisordersThrombosis
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Patient & Survivor CareAggressive LymphomasALLAMLB Cell LymphomaCLLCML
ASCO Releases Vaccination Guidelines for Adults With CancerMarch 28, 2024ASCO Breast CancerASCO Lung CancerMultiple MyelomaMyelodysplastic Syndrome
Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024PediatricsPatient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Most Cancer Trial Centers Located Closer to White, Affluent PopulationsMarch 21, 2024Patient & Survivor CareDLBCLMixed TopicsPediatricsAggressive LymphomasALLAML
Secondary Cancers Post CAR T Therapy: A Concern?March 20, 2024Cellular TherapyAggressive LymphomasALLAMLAnemiaCLLCML
New Drug Approvals Are the Wrong Metric for Cancer PolicyMarch 20, 2024Mixed TopicsDLBCLPediatricsPatient & Survivor CareAggressive LymphomasALLAML
